EvoLife Laboratories, a world leader in the development of products for skin, oral, nail, hair, hygiene care specifically designed for cancer patients undergoing chemotherapy and radiotherapy, successfully launched its products in the USA. EvoLife Laboratories is present at the annual Oncology Nursing Society (ONS) Congress 2010 in San Diego and utilizes this opportunity to further engage with nurses and caregivers. EvoLife Laboratories has been continuously working with the nursing community all around the EU and Asia… (Source: Health News from Medical News Today) Source: MedWorm: Oral Cancer
Tag: 2010
EvoLife Laboratories Reinforces Its Commitment To Assist Oncology Nurses At The ONS 2010, San Diego
Tags: 2010, Assist, Commitment, Diego, EvoLife, Laboratories, Nurses, Oncology, Reinforces
Abstracts Highlighting Sunesis’ Phase 2 Voreloxin Data Accepted For Presentation At 2010 ASCO Meeting
Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) announced that data from three Phase 2 clinical trials of voreloxin, the company’s lead drug candidate, have been accepted for presentation at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting, which is being held June 4-8 in Chicago, Illinois. The presentations include an oral presentation of final data from the Company’s Phase 2 trial of voreloxin in ovarian cancer, as well as poster discussion sessions of data from its two Phase 2 studies of voreloxin in acute myeloid leukemia (AML)… (Source: Health News from Medical News Today) Source: MedWorm: Oral Cancer
Tags: 2010, Abstracts, Accepted, ASCO, Data, Highlighting, meeting, Phase, presentation, Sunesis', Voreloxin
Delcath’s Phase III Trial Data To Be Presented During American Society Of Clinical Oncology 2010 Annual Meeting In Chicago
Delcath Systems, Inc. (Nasdaq: DCTH), a medical technology company testing its proprietary treatment system for primary and metastatic cancers to the liver, announced that the American Society of Clinical Oncology (ASCO) has accepted an abstract for oral presentation of Delcath’s Phase III Trial Data comparing percutaneous hepatic perfusion with melphalan (PHP-mel) to the best alternative care for patients with hepatic metastases from ocular or cutaneous melanoma for ASCO’s 2010 Annual Meeting, to be held June 4-8, 2010 at McCormick Place in Chicago. James F… (Source: Health News from Medical News Today)
MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative health and news sources.
Source: MedWorm: Oral Cancer
Tags: 2010, American, Annual, Chicago, Clinical, Data, Delcath's, During, meeting, Oncology, Phase, Presented, Society, Trial
Women on pill ‘may live longer’ (BBC News Online, 12 March 2010)
A large scale, 39-year study of over 45,000 women has disputed reports that the oral contraceptive Pill can increase the risk of disease. Published in the British Medical Journal, the study has in fact found a slightly protective effect of long term use of the Pill against conditions such as cancer, heart disease and stroke.
Full article (Source: Society for Endocrinology) Source: MedWorm: Oral Cancer
Tags: 'may, 2010, Live, longer', March, News, Online, pill, Women
2010 Genitourinary Canceers Symposium Merit Award Recipients
Merit Awards recognize the work of oncology fellows who are first authors on outstanding Symposium abstracts. The following fellows have received Merit Awards for their research.
Edwin Jason Abel, MD
M. D. Anderson Cancer Center
Does targeted therapy result in reliable and meaningful primary tumor downstaging in patients with metastatic renal cell carcinoma? (Abstract 318)
Renal Cell Cancer Oral Abstract Session C
03/07/2010 (Source: Kidney Cancer Association)
Source: MedWorm: Oral Cancer
Tags: 2010, Award, Canceers, Genitourinary, Merit, Recipients, Symposium
Dana-Farber Cancer Institute News Tips For February 2010
Esophageal cancer trends are tough to swallow What type of cancer has plummeted in African-Americans, increased in whites, and, in only two generations, become the fastest-rising cancer in the United States? Few would guess it is cancer of the esophagus – the foot-long, muscular tube that channels food from the mouth to the stomach. The disease is relatively rare, but it is often deadly, and its incidence is rising at the rate of 1 percent a year… (Source: Health News from Medical News Today)
MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative health and news sources.
Source: MedWorm: Oral Cancer
Tags: 2010, Cancer, DanaFarber, February, Institute, News, Tips
World Cancer Day 2010
February 4th marks World Cancer Day, a day that bring global awareness to the disease. This year’s theme is “Cancer Can Be Prevented Too” and focuses on the avoiding the common causes of cancer. This is an increased concentration this year of raising awareness about infections that cause cancer.
One of the first cancer causing infection that comes to mind is HPV, which is implicated in the development of cervical cancer and also oral cancer. HPV is a suspected cause of other types of cancer as well and it’s role is being researched. HIV and Hepatitis are two other viral infections that can increase your risk of developing cancer. Less common infections like the Epstein-Barr virus, Kaposi sarcoma-associated herpes virus, and Human T-lymphotrophic virus-1. Cancer remains a global leading c… Source: MedWorm: Oral Cancer